ARTICLES
SLT on the Front Line
Gregor Hawlina and Matej Beltram, consultant eye surgeons from Ljubljana, Slovenia, discuss the rise of selective laser trabeculoplasty in the treatment of glaucoma.
Select SLT – and drop drops: SLT as a safe first-line option for glaucoma and ocular hypertension – with OptoYag&SLT (August 2019):
New data show that selective laser trabeculoplasty is a safe first-line option for glaucoma and ocular hypertension. The effect on clinical practice has been immediate – medications are starting to be considered second line in favor of a simple, painless procedure that can give years of IOP control.
Article about a novel Yag application – with OptoYag&SLT (August 2017):
Article about SLT application with OptoYag&SLT (June 2017):
Article about OptoYag&SLT (January 2017):
Article about OptoYAG M (September 2016):
Article about LacriMax (June, 2016):
- How transcanalicular DCR helps nasolacrimal obstruction – .pdf version
- How transcanalicular DCR helps nasolacrimal obstruction
Clinical references:
- Nd:Yag Capsulotomy for Treating Posterior Capsule Opacification
- Selective Laser Trabeculoplasty in Treatment of Open-Angle Glaucoma
- Transcanalicular Diode Laser-assisted DacryoCystoRhinostomy
- Š. Štunf Pukl, B. Drnovšek: Impact of laser pulse duration on the reduction of intraocular pressure during selective laser trabeculoplasty, Int. Ophthalmol, DOI 10.1007/s10792-016-0426-x, published 31 December 2016
White papers:
- OptoYag&SLT M: A Two in One Treatment Solution
- Transforming Glaucoma Therapy with the First 1 ns SLT Laser
Other references:
- Hot&New von OPTI, MIDO und AAD (OptoSLT nano)
- Optotek klärt Ihre Sicht (Lacrimax)
